NURS 6630 FINAL EXAM (2024) WALDEN
UNIVERSITY 300 ACTUAL QUESTIONS AND
CORRECT ANSWERS WITH RATIONALE LATEST
UPDATE ALREADY GRADED A+
The NURS 6630 Final Exam at Walden University is a comprehensive
assessment in psychopharmacology, evaluating advanced practice nursing
students' mastery of neurobiology, psychotropic medications, and treatment
planning for psychiatric disorders. The exam covers major drug classes
including antidepressants, mood stabilizers, antipsychotics, anxiolytics,
stimulants, and hypnotics. Students must demonstrate clinical reasoning in
selecting and monitoring medications, understanding pharmacokinetics,
pharmacodynamics, drug interactions, adverse effects, and special population
considerations. The exam emphasizes evidence-based prescribing, safety,
adherence strategies, and integration of psychopharmacology with
psychotherapy. Success requires critical thinking, application of
neurobiological principles, and familiarity with current guidelines for treating
depression, bipolar disorder, schizophrenia, anxiety, ADHD, and substance
use disorders across the lifespan.
SECTION 1: NEUROBIOLOGY AND NEUROTRANSMITTER SYSTEMS
1. A patient asks the PMHNP how psychotropic medications work in the brain.
The most accurate response is that most medications work by:
A. Creating new neurotransmitters that the body does not naturally produce
B. Restoring an imbalance of one or more neurotransmitters that the body already
produces
C. Destroying excess neurotransmitters to prevent overstimulation
D. Changing the structure of brain cells permanently
Answer: B
Rationale: Most psychotropic medications work by restoring an imbalance of
neurotransmitters that the body naturally produces, helping to alleviate symptoms
without introducing foreign substances .
,2. The PMHNP understands that G-protein coupled receptors are targets for several
psychiatric medications. When one of these receptors is activated in a way that
would potentiate an action, the ultimate result is:
A. Immediate changes in neuronal firing
B. Modification of gene expression
C. Direct ion flux across the membrane
D. Rapid neurotransmitter reuptake
Answer: B
Rationale: G-protein coupled receptors trigger slow effector pathways that
ultimately lead to modification of gene expression through second messenger
cascades, unlike ion channels which produce rapid effects .
3. Which statement best characterizes the synaptic cleft?
A. An area where electrical signals are transmitted directly between neurons
B. An area where dendrites and axon terminals are within close proximity,
allowing neurotransmitter release from a presynaptic neuron to interact with
receptors on postsynaptic dendrites
C. A physical barrier that prevents neurotransmitter movement between neurons
D. A structure found only in the peripheral nervous system
Answer: B
Rationale: The synaptic cleft is the space between neurons where neurotransmitters
are released from the presynaptic neuron to interact with receptors on the
postsynaptic neuron, enabling intercellular communication .
4. Glial cells categorized as macroglia play an active and critical role in
glutamatergic neurotransmission by:
A. Phagocytosing excess neurotransmitters
B. Providing a co-agonist required for glutamate receptor function
C. Myelinating axons only
D. Producing dopamine for synaptic transmission
Answer: B
Rationale: Macroglial cells provide a co-agonist required for glutamate receptor
function, playing an essential role in glutamatergic neurotransmission .
5. The major excitatory neurotransmitter in the central nervous system is:
A. GABA
B. Glycine
C. Glutamate
D. Acetylcholine
Answer: C
,Rationale: Glutamate is the primary excitatory neurotransmitter in the central
nervous system, involved in learning, memory, and synaptic plasticity .
6. Which of the following is an inhibitory neurotransmitter?
A. Glutamate
B. Acetylcholine
C. Dopamine
D. GABA
Answer: D
Rationale: GABA and glycine are the major inhibitory neurotransmitters in the
central nervous system, counterbalancing excitatory neurotransmission .
7. When dopamine D2 receptors are blocked in the nigrostriatal pathway, which
side effect is most likely to occur?
A. Sedation
B. Extrapyramidal symptoms
C. Weight gain
D. Hyperprolactinemia
Answer: B
Rationale: Blockade of dopamine D2 receptors in the nigrostriatal pathway leads to
extrapyramidal symptoms, including parkinsonism, akathisia, and dystonia .
8. Serotonin is primarily involved in regulating which functions?
A. Motor control and coordination
B. Mood, sleep, and psychosis
C. Memory and executive function
D. Fight-or-flight response
Answer: B
Rationale: Serotonin (5HT) is a neurotransmitter associated with mood, sleep, and
psychosis, with multiple receptor types found throughout the body .
9. The PMHNP explains to a student that ionotropic receptors are characterized by:
A. Slow effector pathways through second messengers
B. Rapid effector pathways involving ion flux through ligand-gated channels
C. Gene expression modification
D. G-protein coupling
Answer: B
Rationale: Ionotropic receptors are ligand-gated ion channels that produce rapid
effector pathways through direct ion flux, unlike metabotropic receptors which use
slower second messenger systems .
, 10. Which neurotransmitter system is primarily involved in the pathophysiology of
schizophrenia?
A. Serotonin only
B. Dopamine and glutamate
C. GABA only
D. Acetylcholine and norepinephrine
Answer: B
Rationale: The dopamine hypothesis and glutamatergic dysfunction are central to
the pathophysiology of schizophrenia, with antipsychotics targeting these systems .
11. Acetylcholine is found in which locations in the nervous system?
A. Only in the peripheral nervous system
B. Motor neurons, basal ganglia, nucleus basalis of Meynert, and autonomic
nervous system
C. Only in the cerebral cortex
D. Exclusively in the spinal cord
Answer: B
Rationale: Acetylcholine is found in motor neurons, the basal ganglia, nucleus
basalis of Meynert, and both sympathetic and parasympathetic autonomic nervous
systems .
12. The PMHNP understands that medications used to treat Alzheimer's disease
primarily target which neurotransmitter system?
A. Dopaminergic
B. Serotonergic
C. Cholinergic
D. Noradrenergic
Answer: C
Rationale: Cholinesterase inhibitors used in Alzheimer's disease work by inhibiting
acetylcholinesterase, increasing acetylcholine availability in the synaptic cleft .
13. An inverse agonist differs from a partial agonist in that an inverse agonist:
A. Produces a full response at the receptor
B. Blocks the receptor without any activity
C. Reduces receptor activity below baseline levels
D. Has no effect on receptor activity
Answer: C
UNIVERSITY 300 ACTUAL QUESTIONS AND
CORRECT ANSWERS WITH RATIONALE LATEST
UPDATE ALREADY GRADED A+
The NURS 6630 Final Exam at Walden University is a comprehensive
assessment in psychopharmacology, evaluating advanced practice nursing
students' mastery of neurobiology, psychotropic medications, and treatment
planning for psychiatric disorders. The exam covers major drug classes
including antidepressants, mood stabilizers, antipsychotics, anxiolytics,
stimulants, and hypnotics. Students must demonstrate clinical reasoning in
selecting and monitoring medications, understanding pharmacokinetics,
pharmacodynamics, drug interactions, adverse effects, and special population
considerations. The exam emphasizes evidence-based prescribing, safety,
adherence strategies, and integration of psychopharmacology with
psychotherapy. Success requires critical thinking, application of
neurobiological principles, and familiarity with current guidelines for treating
depression, bipolar disorder, schizophrenia, anxiety, ADHD, and substance
use disorders across the lifespan.
SECTION 1: NEUROBIOLOGY AND NEUROTRANSMITTER SYSTEMS
1. A patient asks the PMHNP how psychotropic medications work in the brain.
The most accurate response is that most medications work by:
A. Creating new neurotransmitters that the body does not naturally produce
B. Restoring an imbalance of one or more neurotransmitters that the body already
produces
C. Destroying excess neurotransmitters to prevent overstimulation
D. Changing the structure of brain cells permanently
Answer: B
Rationale: Most psychotropic medications work by restoring an imbalance of
neurotransmitters that the body naturally produces, helping to alleviate symptoms
without introducing foreign substances .
,2. The PMHNP understands that G-protein coupled receptors are targets for several
psychiatric medications. When one of these receptors is activated in a way that
would potentiate an action, the ultimate result is:
A. Immediate changes in neuronal firing
B. Modification of gene expression
C. Direct ion flux across the membrane
D. Rapid neurotransmitter reuptake
Answer: B
Rationale: G-protein coupled receptors trigger slow effector pathways that
ultimately lead to modification of gene expression through second messenger
cascades, unlike ion channels which produce rapid effects .
3. Which statement best characterizes the synaptic cleft?
A. An area where electrical signals are transmitted directly between neurons
B. An area where dendrites and axon terminals are within close proximity,
allowing neurotransmitter release from a presynaptic neuron to interact with
receptors on postsynaptic dendrites
C. A physical barrier that prevents neurotransmitter movement between neurons
D. A structure found only in the peripheral nervous system
Answer: B
Rationale: The synaptic cleft is the space between neurons where neurotransmitters
are released from the presynaptic neuron to interact with receptors on the
postsynaptic neuron, enabling intercellular communication .
4. Glial cells categorized as macroglia play an active and critical role in
glutamatergic neurotransmission by:
A. Phagocytosing excess neurotransmitters
B. Providing a co-agonist required for glutamate receptor function
C. Myelinating axons only
D. Producing dopamine for synaptic transmission
Answer: B
Rationale: Macroglial cells provide a co-agonist required for glutamate receptor
function, playing an essential role in glutamatergic neurotransmission .
5. The major excitatory neurotransmitter in the central nervous system is:
A. GABA
B. Glycine
C. Glutamate
D. Acetylcholine
Answer: C
,Rationale: Glutamate is the primary excitatory neurotransmitter in the central
nervous system, involved in learning, memory, and synaptic plasticity .
6. Which of the following is an inhibitory neurotransmitter?
A. Glutamate
B. Acetylcholine
C. Dopamine
D. GABA
Answer: D
Rationale: GABA and glycine are the major inhibitory neurotransmitters in the
central nervous system, counterbalancing excitatory neurotransmission .
7. When dopamine D2 receptors are blocked in the nigrostriatal pathway, which
side effect is most likely to occur?
A. Sedation
B. Extrapyramidal symptoms
C. Weight gain
D. Hyperprolactinemia
Answer: B
Rationale: Blockade of dopamine D2 receptors in the nigrostriatal pathway leads to
extrapyramidal symptoms, including parkinsonism, akathisia, and dystonia .
8. Serotonin is primarily involved in regulating which functions?
A. Motor control and coordination
B. Mood, sleep, and psychosis
C. Memory and executive function
D. Fight-or-flight response
Answer: B
Rationale: Serotonin (5HT) is a neurotransmitter associated with mood, sleep, and
psychosis, with multiple receptor types found throughout the body .
9. The PMHNP explains to a student that ionotropic receptors are characterized by:
A. Slow effector pathways through second messengers
B. Rapid effector pathways involving ion flux through ligand-gated channels
C. Gene expression modification
D. G-protein coupling
Answer: B
Rationale: Ionotropic receptors are ligand-gated ion channels that produce rapid
effector pathways through direct ion flux, unlike metabotropic receptors which use
slower second messenger systems .
, 10. Which neurotransmitter system is primarily involved in the pathophysiology of
schizophrenia?
A. Serotonin only
B. Dopamine and glutamate
C. GABA only
D. Acetylcholine and norepinephrine
Answer: B
Rationale: The dopamine hypothesis and glutamatergic dysfunction are central to
the pathophysiology of schizophrenia, with antipsychotics targeting these systems .
11. Acetylcholine is found in which locations in the nervous system?
A. Only in the peripheral nervous system
B. Motor neurons, basal ganglia, nucleus basalis of Meynert, and autonomic
nervous system
C. Only in the cerebral cortex
D. Exclusively in the spinal cord
Answer: B
Rationale: Acetylcholine is found in motor neurons, the basal ganglia, nucleus
basalis of Meynert, and both sympathetic and parasympathetic autonomic nervous
systems .
12. The PMHNP understands that medications used to treat Alzheimer's disease
primarily target which neurotransmitter system?
A. Dopaminergic
B. Serotonergic
C. Cholinergic
D. Noradrenergic
Answer: C
Rationale: Cholinesterase inhibitors used in Alzheimer's disease work by inhibiting
acetylcholinesterase, increasing acetylcholine availability in the synaptic cleft .
13. An inverse agonist differs from a partial agonist in that an inverse agonist:
A. Produces a full response at the receptor
B. Blocks the receptor without any activity
C. Reduces receptor activity below baseline levels
D. Has no effect on receptor activity
Answer: C
